Cargando…
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patie...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532780/ https://www.ncbi.nlm.nih.gov/pubmed/28750634 http://dx.doi.org/10.1186/s12933-017-0576-9 |
_version_ | 1783253522021613568 |
---|---|
author | Hernández, Marta López, Carolina Real, Jordi Valls, Joan Ortega-Martinez de Victoria, Emilio Vázquez, Federico Rubinat, Esther Granado-Casas, Minerva Alonso, Nuria Molí, Teresa Betriu, Angels Lecube, Albert Fernández, Elvira Leslie, Richard David Mauricio, Dídac |
author_facet | Hernández, Marta López, Carolina Real, Jordi Valls, Joan Ortega-Martinez de Victoria, Emilio Vázquez, Federico Rubinat, Esther Granado-Casas, Minerva Alonso, Nuria Molí, Teresa Betriu, Angels Lecube, Albert Fernández, Elvira Leslie, Richard David Mauricio, Dídac |
author_sort | Hernández, Marta |
collection | PubMed |
description | BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patients with classic type 1 diabetes and type 2 diabetes. METHODS: Patients with LADA were matched for age and gender in different proportions to patients with type 2 diabetes, and classic type 1 diabetes. None of the patients had clinical cardiovascular disease. All subjects underwent B-mode carotid ultrasound to detect atheroma plaques. Demographics were obtained from all subjects. RESULTS: We included 71 patients with LADA, 191 patients with type 2 diabetes and 116 patients with type 1 diabetes. Carotid atherosclerosis was more frequent in patients with LADA compared with type 2 diabetes (73.2% vs. 56.9%, P = 0.0018) and classic type 1 diabetes (57.1%, P = 0.026); these changes occurred despite healthier macrovascular risk profiles in the former. Age (P < 0.001), smoking (P = 0.003) and hypertension (P = 0.019) were independently associated with carotid atherosclerosis. Multiple plaques were also more frequent in patients with LADA as compared with classic type 1 diabetes and type 2 diabetes (45.1% and 33.6% vs. 27.2%, respectively, P = 0.022). The frequency of carotid plaques increased with increasing diabetes duration in LADA patients compared with type 2 diabetes (85.7% vs. 58.8%, inverse OR 5.72 [1.5–21.8]; P = 0.009). CONCLUSIONS: LADA patients do not present with less carotid atherosclerosis than patients with type 1 and type 2 diabetes. Their macrovascular risk occurs despite a healthier macrovascular risk profile than those patients with type 2 diabetes. |
format | Online Article Text |
id | pubmed-5532780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55327802017-08-02 Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes Hernández, Marta López, Carolina Real, Jordi Valls, Joan Ortega-Martinez de Victoria, Emilio Vázquez, Federico Rubinat, Esther Granado-Casas, Minerva Alonso, Nuria Molí, Teresa Betriu, Angels Lecube, Albert Fernández, Elvira Leslie, Richard David Mauricio, Dídac Cardiovasc Diabetol Original Investigation BACKGROUND: LADA is probably the most prevalent form of autoimmune diabetes. Nevertheless, there are few data about cardiovascular disease in this group of patients. The aim of this study was to investigate the frequency of carotid atherosclerotic plaques in patients with LADA as compared with patients with classic type 1 diabetes and type 2 diabetes. METHODS: Patients with LADA were matched for age and gender in different proportions to patients with type 2 diabetes, and classic type 1 diabetes. None of the patients had clinical cardiovascular disease. All subjects underwent B-mode carotid ultrasound to detect atheroma plaques. Demographics were obtained from all subjects. RESULTS: We included 71 patients with LADA, 191 patients with type 2 diabetes and 116 patients with type 1 diabetes. Carotid atherosclerosis was more frequent in patients with LADA compared with type 2 diabetes (73.2% vs. 56.9%, P = 0.0018) and classic type 1 diabetes (57.1%, P = 0.026); these changes occurred despite healthier macrovascular risk profiles in the former. Age (P < 0.001), smoking (P = 0.003) and hypertension (P = 0.019) were independently associated with carotid atherosclerosis. Multiple plaques were also more frequent in patients with LADA as compared with classic type 1 diabetes and type 2 diabetes (45.1% and 33.6% vs. 27.2%, respectively, P = 0.022). The frequency of carotid plaques increased with increasing diabetes duration in LADA patients compared with type 2 diabetes (85.7% vs. 58.8%, inverse OR 5.72 [1.5–21.8]; P = 0.009). CONCLUSIONS: LADA patients do not present with less carotid atherosclerosis than patients with type 1 and type 2 diabetes. Their macrovascular risk occurs despite a healthier macrovascular risk profile than those patients with type 2 diabetes. BioMed Central 2017-07-28 /pmc/articles/PMC5532780/ /pubmed/28750634 http://dx.doi.org/10.1186/s12933-017-0576-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Hernández, Marta López, Carolina Real, Jordi Valls, Joan Ortega-Martinez de Victoria, Emilio Vázquez, Federico Rubinat, Esther Granado-Casas, Minerva Alonso, Nuria Molí, Teresa Betriu, Angels Lecube, Albert Fernández, Elvira Leslie, Richard David Mauricio, Dídac Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title | Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title_full | Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title_fullStr | Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title_full_unstemmed | Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title_short | Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes |
title_sort | preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (lada), type 2 diabetes and classical type 1 diabetes |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532780/ https://www.ncbi.nlm.nih.gov/pubmed/28750634 http://dx.doi.org/10.1186/s12933-017-0576-9 |
work_keys_str_mv | AT hernandezmarta preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT lopezcarolina preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT realjordi preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT vallsjoan preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT ortegamartinezdevictoriaemilio preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT vazquezfederico preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT rubinatesther preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT granadocasasminerva preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT alonsonuria preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT moliteresa preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT betriuangels preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT lecubealbert preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT fernandezelvira preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT lesliericharddavid preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes AT mauriciodidac preclinicalcarotidatherosclerosisinpatientswithlatentautoimmunediabetesinadultsladatype2diabetesandclassicaltype1diabetes |